Provides industry leading insights leveraging clinical, financial and operational data
Today at HIMSS14, ConvergeHEALTH by Deloitte announces the availability of Health System Intellect, an industry leading analytics solution that provides integrated views of clinical, operational and financial analytics to optimize reporting and performance at the process and key performance indicator level.
Health System Intellect will help health systems:
ConvergeHEALTH's Health System Intellect suite, combined with Deloitte's practices in clinical information systems, revenue cycle, clinical effectiveness, decision support and performance improvement, will allow health systems to lower cost of services, increase patient satisfaction, align revenue with value, reduce unnecessary utilization and process variation, enable continuous improvement programs, and improve knowledge sharing across functions.
"Health systems are facing tremendous challenges to reduce costs, improve quality and work within new reimbursement models," said Asif Dhar, principal, Deloitte Consulting LLP, chief medical informatics officer and executive vice president of solutions for ConvergeHEALTH. "Our analytics will enable organizations to have a more complete view of performance so that decisions about cost are not made at the expense of quality, nor do they sub-optimize performance in other areas of the health system.
"The analytics will help clients get to the root cause of performance issues, pinpointing manageable clinical, operational and financial process variance so that organizations can improve quality while decreasing cost and maximizing revenue," Dhar continued. "Combined with Deloitte's proven approaches to managing cost, quality and revenue, our analytics solutions focus teams on measures, actions and real team-oriented solutions."
"Deloitte's consulting practices have been guiding health care organizations to improve their clinical and operational performance for many years, and now clients can benefit by having an enterprise analytics environment to drive continuous improvement through the Intellect integrated platform for organizational transformation," said Doug Beaudoin, principal, Deloitte Consulting LLP and a leader of Deloitte's life sciences and health care practice. "We are proud to continue to help health systems use data to transform their clinical and operational enterprises for the ultimate benefit of patients."
ConvergeHEALTH is showcasing its solutions in Orlando, Fla., Feb. 23-26 at the HIMSS14 conference in Booth 1611.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
June 26th 2025The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with hemophilia A or B with inhibitors, offering a promising new prophylactic option for a population with limited therapeutic choices.